Pyxis Oncology (PYXS) Treasury Shares (2020 - 2025)

Pyxis Oncology (PYXS) has 6 years of Treasury Shares data on file, last reported at $1.6 million in Q4 2025.

• On a quarterly basis, Treasury Shares fell 35.49% year-over-year to $1.6 million in Q4 2025; TTM through Dec 2025 was $1.6 million, a 35.49% decrease from a year earlier, with the FY2025 full-year figure at $1.6 million, down 35.49% from the prior year.
• Treasury Shares for Q4 2025 stood at $1.6 million, down from $1.8 million in the prior quarter.
• Over the last five years, Treasury Shares for PYXS reached as high as $127.5 million in Q1 2021 and fell as low as $618494.0 in Q4 2021.
• Historically, Treasury Shares has averaged $21.6 million across 5 years, with a median of $3.1 million in 2024.
• Across the five-year window, Treasury Shares soared 461.22% in 2021 and slumped 97.68% in 2022, its largest moves.
• Year by year, Treasury Shares stood at $618494.0 in 2021, then surged by 387.54% to $3.0 million in 2022, then grew by 20.43% to $3.6 million in 2023, then sank by 30.23% to $2.5 million in 2024, then sank by 35.49% to $1.6 million in 2025.
• Per Business Quant data, the three most recent Treasury Shares figures were $1.6 million in Q4 2025, $1.8 million in Q3 2025, and $1.9 million in Q2 2025.